GlassScriptPhysician profile
William J Nazzaro
NPI 1306008586
$5,887.26
in general payments reported to CMS, 2019-2025
32 companies · $358 in 2025
The $358 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,489 · 2020: $348 · 2021: $695 · 2022: $608 · 2023: $677 · 2024: $713 · 2025: $358.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,748.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,747.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $2,061.52 | 2019-2025 | Lifevest |
| Biotronik INC. | $493.73 | 2019-2024 | Biomonitor, Renamic Neo |
| Janssen Pharmaceuticals, INC | $394.75 | 2020-2023 | Xarelto |
| Novartis Pharmaceuticals Corporation | $387.63 | 2019-2025 | |
| Astellas Pharma US INC | $319.33 | 2019-2021 | |
| Amgen INC. | $307.47 | 2019-2024 | Repatha |
| Boston Scientific Corporation | $300.73 | 2019-2024 | Watchman Flx, Watchman Access System |
| Abbott Laboratories | $238.48 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Pfizer INC. | $165.71 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $154.88 | 2019-2024 | Eliquis, Camzyos |
| Kestra Medical Technology Services, INC. | $145.55 | 2024 | Assure Wcd |
| Novo Nordisk INC | $139.99 | 2020-2025 | Wegovy |
| Edwards Lifesciences Corporation | $122.86 | 2019-2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Kiniksa Pharmaceuticals, LTD. | $116.44 | 2022-2023 | Arcalyst |
| Merck Sharp & Dohme LLC | $87.53 | 2021-2023 | Verquvo |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $44.24 | 2020-2021 | |
| Scpharmaceuticals INC. | $41.21 | 2023-2024 | |
| Lilly USA, LLC | $38.52 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.75 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $37.41 | 2019-2022 | |
| Cvrx, INC. | $31.04 | 2025 | Barostim Neo System |
| Alnylam Pharmaceuticals INC. | $28.85 | 2022-2023 | Onpattro |
| Cleerly, INC. | $26.05 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $24.21 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $23.85 | 2020-2021 | |
| Lexicon Pharmaceuticals, INC. | $23.36 | 2024 | |
| Glaxosmithkline, LLC. | $21.32 | 2025 | Arexvy |
| Octapharma USA, INC. | $17.17 | 2025 | Fibryga |
| Abiomed | $15.77 | 2024 | Impella |
| Baxter Healthcare | $15.63 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Livanova USA, INC. | $13.14 | 2023 | Lifesparc |
| Zoll Circulation INC | $11.14 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Nazzaro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.